ADAM17 as a promising molecular target for organ protection in antihypertensive therapy
American Journal of Hypertension · 01.09.2026 · 39 (9) · 1055-1058
DOI: 10.1093/ajh/hpag071 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Hypertension, online erschienen am 02.07.2026. Verfasst von Alexander E Berezin. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine II, Paracelsus Medical University Salzburg, Salzburg, Austria. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine II, Paracelsus Medical University Salzburg, Salzburg, Austria.
ORCID-Profile: Alexander E Berezin
Zitieren
APA
Berezin, A. E. (2026). ADAM17 as a promising molecular target for organ protection in antihypertensive therapy. American Journal of Hypertension, 39(9), 1055-1058. https://doi.org/10.1093/ajh/hpag071
Vancouver
Berezin AE. ADAM17 as a promising molecular target for organ protection in antihypertensive therapy. American Journal of Hypertension. 2026;39(9):1055-1058. doi:10.1093/ajh/hpag071
BibTeX
@article{Berezin2026,
author = {Berezin, Alexander E},
title = {ADAM17 as a promising molecular target for organ protection in antihypertensive therapy},
journal = {American Journal of Hypertension},
year = {2026},
volume = {39},
number = {9},
pages = {1055--1058},
doi = {10.1093/ajh/hpag071}
}
EUVIMED